Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01UVD
|
||||
| Former ID |
DNC013702
|
||||
| Drug Name |
N-(2-iodoethyl)linoleoylamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529848] | ||
| Formula |
C20H36INO
|
||||
| Canonical SMILES |
CCCCCC=CCC=CCCCCCCCC(=O)NCCI
|
||||
| InChI |
1S/C20H36INO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)22-19-18-21/h6-7,9-10H,2-5,8,11-19H2,1H3,(H,22,23)/b7-6-,10-9-
|
||||
| InChIKey |
WVKIJZMEKURTIW-HZJYTTRNSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529848] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.